UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009479
Receipt number R000011137
Scientific Title A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patients
Date of disclosure of the study information 2012/12/05
Last modified on 2017/02/24 11:14:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patients

Acronym

Comparative study of peramivir and
oseltamivir in the influenza virus
infection

Scientific Title

A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patients

Scientific Title:Acronym

Comparative study of peramivir and
oseltamivir in the influenza virus
infection

Region

Japan


Condition

Condition

Influenza virus infection

Classification by specialty

Medicine in general Pneumology Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of clinical and viral effects of peramivir compared with oseltamivir in high-risk patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The duration of fever

Key secondary outcomes

Symptoms of influenza infection, viral titer and subtype, complications, exacerbation of underlying diseases, H275Y mutation of the virus isolated from the patients with poor clinical effects,
The detection of colonized pneumococcus in nasal pharynx in the patients complicated secondary bacterial pneumonia


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Peramivir,
Intravenously administration
600mg once a day, allowing daily injection if the patient condition is severe.

Interventions/Control_2

Oseltamivir,
Orally administration, 75mg twice a day for 5 days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients who satisfied below 1)-7):
1)Age:>=20
2)Agreement with documents
3)Fever>=38.0 degrees centigrade
4)>=2 items of ISS* which as moderate symptoms
5)Within 48hour after onset:
Onset time is defined as below
(1)First time at increase of body temperature (>=1 degrees centigrade as usual)
(2)First time which the patient
aware >=1 items of ISS*
6)Positive for Rapid Antigen Test kit
7)With at least one risk factor

*ISS=Influenza Symptoms Severity

Key exclusion criteria

1)contraindication of peramivir and oseltamivir
2)pregnant or probable pregnant women
3)Inappropriate judged by doctors
4)pneumonia on the 1st day of visiting hospital

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shigeki Nakamura

Organization

Nagasaki University Hospital

Division name

Second Department of Internal Medicine

Zip code


Address

1-7-1, Sakamoto, Nagasaki city, Nagasaki prefecture.

TEL

095-819-7273

Email

moju516@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Taiga Miyazaki

Organization

Nagasaki evaluation organization for clinical interventions

Division name

office

Zip code


Address

1-7-1, Sakamoto, Nagasaki city, Nagasaki prefecture.

TEL

095-819-7273

Homepage URL


Email

shinkin@peath.co.jp


Sponsor or person

Institute

Nagasaki evaluation organization for clinical interventions

Institute

Department

Personal name



Funding Source

Organization

Nagasaki evaluation organization for clinical interventions

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

・長崎大学病院(長崎県)
・日本赤十字社長崎原爆病院(長崎県)
・日本赤十字社長崎原爆諫早病院(長崎県)
・地方独立行政法人 北松中央病院(長崎県)
・佐世保市立総合病院(長崎県)
・独立行政法人国立病院機構 嬉野医療センター(佐賀県)
・長崎市立市民病院(長崎県)
・医療法人 光晴会病院(長崎県)
・医療法人 栄和会 泉川病院(長崎県)
・健康保険諫早総合病院(長崎県)
・千住診療所(長崎県)
・おにつか内科・消化器科(長崎県)
・医療法人 ともなが内科クリニック(長崎県)
・入船クリニック(長崎県)
・かわむら内科(長崎県)
・重野医院(長崎県)


Other administrative information

Date of disclosure of the study information

2012 Year 12 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 11 Month 22 Day

Date of IRB


Anticipated trial start date

2012 Year 11 Month 27 Day

Last follow-up date

2014 Year 06 Month 30 Day

Date of closure to data entry

2014 Year 08 Month 31 Day

Date trial data considered complete

2014 Year 10 Month 31 Day

Date analysis concluded

2014 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 12 Month 04 Day

Last modified on

2017 Year 02 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011137


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name